Reply to 'Consider more about risk scores for predicting hepatocellular carcinoma in patients with chronic hepatitis B'

被引：1
|
作者：
Kamalapirat, Thanachote [1 ]
Ungtrakul, Teerapat [1 ]
机构：
[1] Chulabhorn Royal Acad, Fac Med & Publ Hlth, HRH Princess Chulabhorn Coll Med Sci, Bangkok, Thailand
来源：
JOURNAL OF VIRAL HEPATITIS | 2021年 / 28卷 / 10期
关键词：
D O I：
10.1111/jvh.13566
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：1501 / 1501
页数：1
相关论文
共 50 条
  • [21] A scoring system in predicting the risk of hepatocellular carcinoma in chronic hepatitis B carrier
    Chan, S. L.
    Mo, F.
    Wong, V. W.
    Wong, G. L.
    Loong, H. H.
    Chan, V.
    Chan, A. T.
    Yeo, W.
    Chan, H. L.
    Mok, T.
    EJC SUPPLEMENTS, 2009, 7 (02): : 366 - 366
  • [22] Risk of hepatocellular carcinoma with tenofovir versus entecavir in chronic hepatitis B Reply
    Tseng, Cheng-Hao
    Hsu, Yao-Chun
    Nguyen, Mindie H.
    LANCET GASTROENTEROLOGY & HEPATOLOGY, 2021, 6 (02): : 87 - 88
  • [23] Individualized surveillance of chronic hepatitis B patients according to hepatocellular carcinoma risk based on PAGE-B scores
    Kim, Ji Hyun
    Kang, Seong Hee
    Lee, Minjong
    Choi, Hoon Sung
    Jun, Baek Gyu
    Kim, Tae Suk
    Choi, Dae Hee
    Suk, Ki Tae
    Kim, Moon Young
    Kim, Young Don
    Cheon, Gab Jin
    Baik, Soon Koo
    Kim, Dong Joon
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2021, 33 (12) : 1564 - 1572
  • [24] Authors' response: Additional more factors should be included in predicting risk of hepatocellular carcinoma in patients with chronic hepatitis B virus infection
    Chang, Jin Won
    Kim, Seung Up
    JOURNAL OF VIRAL HEPATITIS, 2021, 28 (03) : 574 - 574
  • [25] Letter: serum hepatitis B virus DNA and risk of hepatocellular carcinoma in patients with chronic hepatitis B-authors' reply
    Kim, Gi-Ae
    Lim, Young-Suk
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2021, 53 (06) : 763 - 763
  • [26] Predicting Hepatocellular Carcinoma Risk in Chronic Hepatitis B Patients Receiving Finite Periods of Antiviral Therapy
    Lin, Chih-Lang
    Wu, Szu-Yuan
    Lai, Ming-Wei
    Hsu, Chao-Wei
    Chen, Wan-Ming
    Jao, An-Tzu
    Chien, Cheng-Hung
    Hu, Ching-Chih
    Chien, Rong-Nan
    Yeh, Chau-Ting
    CANCERS, 2023, 15 (13)
  • [27] EVALUATION OF RISK SCORES FOR HEPATOCELLULAR CARCINOMA IN CHRONIC HEPATITIS B PATIENTS IN A LARGE, REPRESENTATIVE, NORTHERN CALIFORNIA COHORT
    Saxena, Varun
    Liu, Liyan
    Chai, Krisna P.
    Seo, Suk
    Mukhtar, Nizar A.
    Balasubramanian, Sripriya
    Macdonald, Brock A.
    Ready, Joanna B.
    Schmittdiel, Julie A.
    HEPATOLOGY, 2021, 74 : 689A - 689A
  • [28] Is Tenofovir Associated with a Lower Risk of Hepatocellular Carcinoma in Patients with Chronic Hepatitis B Compared With Entecavir? Reply
    Yip, Terry Cheuk-Fung
    Wong, Grace Lai-Hung
    GASTROENTEROLOGY, 2020, 158 (08) : 2312 - 2313
  • [29] Risk Factors for Hepatocellular Carcinoma in Cirrhotic Patients with Chronic Hepatitis B
    Zhang, Yuan-Qing
    Peng, Li-Jun
    Cao, Yi-Rong
    Zeng, Zhi-Ping
    Wu, Yu-Jing
    Shi, Hong
    Cheng, Shi-Yao
    Wang, Ji-Yao
    Friedman, Scott L.
    Sninsky, John J.
    Guo, Jin-Sheng
    GENETIC TESTING AND MOLECULAR BIOMARKERS, 2016, 20 (09) : 535 - 543
  • [30] Statin Use and the Risk of Hepatocellular Carcinoma in Patients With Chronic Hepatitis B
    Goh, Myung Ji
    Sinn, Dong Hyun
    Kim, Seonwoo
    Woo, Sook Young
    Cho, Hyun
    Kang, Wonseok
    Gwak, Geum-Youn
    Paik, Yong-Han
    Choi, Moon Seok
    Lee, Joon Hyeok
    Koh, Kwang Cheol
    Paik, Seung Woon
    HEPATOLOGY, 2020, 71 (06) : 2023 - 2032
12345